Adina Kalmanowitz
Family · Brooklyn, NYNPI 1144748336
Payments from drug & device makers
Across 140 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$693
- AbbVie$456
- Novo Nordisk$441
- Phathom Pharmaceuticals, Inc.$224
- Exact Sciences$142
- AstraZeneca$131
- plus $696 from 17 others
What the payments were for
- Food & beverage$2,784100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 39 | $693 |
| AbbVie | 22 | $456 |
| Novo Nordisk | 17 | $441 |
| Phathom Pharmaceuticals, Inc. | 14 | $224 |
| Exact Sciences | 6 | $142 |
| AstraZeneca | 6 | $131 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $106 |
| E.r. Squibb & Sons, L.L.C. | 3 | $97 |
| GSK | 5 | $79 |
| Johnson & Johnson | 3 | $61 |
| Sanofi-aventis U.S. LLC | 3 | $60 |
| Merck | 4 | $59 |
| Astellas Pharma US Inc | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $27 |
| Novartis | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Amgen | 1 | $22 |
| Alkermes, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Vistapharm, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,784 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $16,445 |
| JardianceEmpagliflozin | 20 | $13,920 |
| JanuviaSitagliptin Phosphate | 21 | $13,453 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,796 |
| FarxigaDapagliflozin Propanediol | 11 | $8,413 |
| VascepaIcosapent Ethyl | 12 | $4,944 |
| Rosuvastatin Calcium | 61 | $836 |
| Ventolin HfaAlbuterol Sulfate | 11 | $578 |
| Ketoconazole | 11 | $554 |
| Omeprazole | 37 | $520 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $517 |
| Metoprolol Succinate | 34 | $390 |
| Losartan Potassium | 40 | $387 |
| Atorvastatin Calcium | 49 | $359 |
| Fluticasone Propionate | 39 | $348 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Farxiga | $131 | $19,20928 claims |
| Novo NordiskOzempic | $441 | $16,44518 claims |
| Boehringer IngelheimJardiance | $19 | $13,92020 claims |
| MerckJanuvia | $59 | $13,45321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,883 family providers in New York.
Other family in Brooklyn
- Seida VelijaBrooklyn$62K
- Ofiong OkonBrooklyn$44K
- Irina FainbergBrooklyn$23K
- Susan WeissBrooklyn$22K
- Razan AlawadhiBrooklyn$21K
- Christina LaoBrooklyn$20K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.